Results 101 to 110 of about 11,011 (206)

Specific role of combination aclidinium: formoterol in the treatment of chronic obstructive pulmonary disease

, 2016
Maria Gabriella Matera,1 Alessandro Sanduzzi,2 Mario Cazzola3 1Department of Experimental Medicine, Second University of Naples, 2Department of Respiratory Diseases, Monaldi Hospital, University Federico II, Naples, 3Department of Systems Medicine ...
Matera MG, Cazzola M, Sanduzzi A
core  

Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group

, 1997
BACKGROUND: The role of long-acting, inhaled beta2-agonists in treating asthma is uncertain. In a double-blind study, we evaluated the effects of adding inhaled formoterol to both lower and higher doses of the inhaled glucocorticoid budesonide.
Pauwels, Romain A, Barnes, Peter J, Ullman, Anders, Tattersfield, Anne E, Löfdahl, Claes-Göran, Postma, Dirkje S, O'Byrne, Paul   +6 more
core   +1 more source

Formoterol dynamically alters endocannabinoid tone in the periaqueductal gray inducing headache

The Journal of Headache and Pain
Background Headache is a pain disorder present in populations world-wide with a higher incidence in females. Specifically, the incidences of medication overuse headache (MOH) have increased worldwide.
Ingrid L. Peterson, Erika Liktor-Busa, Kelly L. Karlage, Sally J. Young, Natalie E. Scholpa, Rick G. Schnellmann, Tally M. Largent-Milnes   +6 more
doaj   +1 more source

Formoterol Reduces the Pro‐Inflammatory Phenotype by Enhancing the Activity of Glutaminase in Monocyte‐Derived Macrophages in the CVB3‐Induced Viral Myocarditis

Immunity, Inflammation and Disease
Background Viral myocarditis (VMC) plays a significant role in heart failure, and there is currently a shortage of available targeted treatments. Macrophage phenotype and function are closely associated with the beta‐2 adrenergic receptor (β2‐AR). Method
Quan‐liang Li, Hua‐bao Xie, Ying‐xin Guo, Juan‐fen Li, Jing Qian, Wei‐Feng Wu   +5 more
doaj   +1 more source

Formoterol [PDF]

, 2020
openaire   +1 more source

Cost versus utility of aclidinium bromide 400 μg plus formoterol fumarate dihydrate 12 μg compared to aclidinium bromide 400 μg alone in the management of moderate-to-severe COPD

, 2016
Mafalda Ramos,1 John Haughney,2 Nathaniel Henry,3 Leandro Lindner,4 Mark Lamotte1 1Real World Evidence, IMS Health, Zaventem, Belgium; 2Academic Primary Care Division of Applied Health Sciences, University of Aberdeen, Aberdeen, Scotland, 3Health ...
Ramos M, Lamotte M, Haughney J, Lindner L, Henry N   +4 more
core  

Severe exacerbation and pneumonia in COPD patients treated with fixed combinations of inhaled corticosteroid and long-acting beta2 agonist

International Journal of COPD, 2017
Hsi-Hsing Yang,1,2 Chih-Cheng Lai,3 Ya-Hui Wang,4 Wei-Chih Yang,5 Cheng-Yi Wang,4,* Hao-Chien Wang,6,* Likwang Chen,5 Chong-Jen Yu6 On behalf of Taiwan Clinical Trial Consortium for Respiratory Diseases (TCORE) 1Department of Intensive Care Medicine ...
Yang HH, Lai CC, Wang YH, Yang WC, Wang CY, Wang HC, Chen L, Yu CJ   +7 more
doaj  

Incorporating New Guidelines into School-Based Asthma Management. [PDF]

Curr Allergy Asthma Rep
Jindra JM, Hogan AD.
europepmc   +1 more source

Enantioselective disposition of (R,R)-formoterol, (S,S)-formoterol and their respective glucuronides in urine following single inhaled dosing and application to doping control

, 2019
Formoterol is a long‐acting beta2‐adrenoceptor agonist (LABA) used for treatment of asthma and exercise‐induced bronchoconstriction. Formoterol is usually administered as a racemic (rac‐) mixture of (R,R)‐ and (S,S)‐enantiomers.
Glenn Jacobson (14740078), David Nichols (14745454), Eugene Walters (14752090), Hostrup, M (15639605), Christian Narkowicz (14745160)   +4 more
core  

Beta₂-agonist and anti-inflammatory combination therapy for asthma rescue: a paradigm shift in asthma care. [PDF]

Front Med (Lausanne)
Skolnik N, Stieritz J, Akers J, Hudd T, Wright WL, Gilbert I, Yusufova N, Cook B, Robb E, Naddaf H.   +9 more
europepmc   +1 more source